Hepatitis C virus modulates signal peptide peptidase to alter host protein processing

Significance The mechanism by which hepatitis C virus (HCV) evades immune surveillance and causes chronic infection is unclear. We demonstrate here that HCV core protein interferes with the maturation of major histocompatibility complex (MHC) class I catalyzed by signal peptide peptidase (SPP) and induces degradation via HMG-CoA reductase degradation 1 homolog. In addition, we found that the core protein transmembrane domain is homologous to the human cytomegalovirus US2 protein, whose transmembrane region also targets SPP to impair MHC class I molecule expression in a similar manner. Therefore, our data suggest that SPP represents a potential target for the impairment of MHC class I molecules by DNA and RNA viruses. Immunoevasins are viral proteins that prevent antigen presentation on major histocompatibility complex (MHC) class I, thus evading host immune recognition. Hepatitis C virus (HCV) evades immune surveillance to induce chronic infection; however, how HCV-infected hepatocytes affect immune cells and evade immune recognition remains unclear. Herein, we demonstrate that HCV core protein functions as an immunoevasin. Its expression interfered with the maturation of MHC class I molecules catalyzed by the signal peptide peptidase (SPP) and induced their degradation via HMG-CoA reductase degradation 1 homolog, thereby impairing antigen presentation to CD8+ T cells. The expression of MHC class I in the livers of HCV core transgenic mice and chronic hepatitis C patients was impaired but was restored in patients achieving sustained virological response. Finally, we show that the human cytomegalovirus US2 protein, possessing a transmembrane region structurally similar to the HCV core protein, targets SPP to impair MHC class I molecule expression. Thus, SPP represents a potential target for the impairment of MHC class I molecules by DNA and RNA viruses.

[1]  Shaohui Wang,et al.  Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo , 2019, Journal of Virology.

[2]  T. Horii,et al.  Characterization of SPP inhibitors suppressing propagation of HCV and protozoa , 2017, Proceedings of the National Academy of Sciences.

[3]  J. Kao,et al.  Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. , 2017, Best practice & research. Clinical gastroenterology.

[4]  C. Strassburg,et al.  Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C. , 2017, Journal of hepatology.

[5]  L. Bolondi,et al.  Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. , 2016, Journal of hepatology.

[6]  M. Manns,et al.  Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy , 2016, European journal of immunology.

[7]  R. Elliott,et al.  Bunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidase , 2016, Proceedings of the National Academy of Sciences.

[8]  G. Dougan,et al.  Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens , 2016, Nature Communications.

[9]  Toru Okamoto,et al.  TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis , 2016, Nature Communications.

[10]  S. Akira,et al.  p62 Plays a Specific Role in Interferon-γ-Induced Presentation of a Toxoplasma Vacuolar Antigen. , 2015, Cell reports.

[11]  H. Fuchino,et al.  Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes* , 2015, The Journal of Biological Chemistry.

[12]  D. Langosch,et al.  Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u , 2014, The EMBO journal.

[13]  M. Heim,et al.  Innate and adaptive immune responses in HCV infections. , 2014, Journal of hepatology.

[14]  N. Enomoto,et al.  Hallmarks of Hepatitis C Virus in Equine Hepacivirus , 2014, Journal of Virology.

[15]  G. Dougan,et al.  TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I , 2014, Proceedings of the National Academy of Sciences.

[16]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[17]  S. Bloor,et al.  Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins , 2014, The Journal of cell biology.

[18]  Yoshiharu Matsuura,et al.  Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity , 2014, PloS one.

[19]  R. Colbert,et al.  HLA-B27 misfolding and ankylosing spondylitis. , 2014, Molecular immunology.

[20]  P. Lehner,et al.  MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation , 2013, Proceedings of the National Academy of Sciences.

[21]  Ralf Bartenschlager,et al.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.

[22]  H. Wedemeyer,et al.  Natural history of acute and chronic hepatitis C. , 2012, Best practice & research. Clinical gastroenterology.

[23]  Wei Li,et al.  Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. , 2011, The Journal of clinical investigation.

[24]  A. Muir,et al.  Direct-acting antiviral medications for chronic hepatitis C virus infection. , 2011, Gastroenterology & hepatology.

[25]  P. Lehner,et al.  HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation , 2011, Proceedings of the National Academy of Sciences.

[26]  P. Bates,et al.  Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein , 2010, PLoS pathogens.

[27]  Mair E. M. Thomas,et al.  The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER , 2009, The Journal of cell biology.

[28]  Bindu Nanduri,et al.  Bovine viral diarrhea virus infection affects the expression of proteins related to professional antigen presentation in bovine monocytes. , 2009, Biochimica et biophysica acta.

[29]  M. Takeda,et al.  Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation , 2008, Journal of Virology.

[30]  S. Emerson,et al.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.

[31]  Y. Matsuura,et al.  Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver. , 2008, The international journal of biochemistry & cell biology.

[32]  M. Knittler,et al.  Molecular Architecture of the TAP-Associated MHC Class I Peptide-Loading Complex1 , 2007, The Journal of Immunology.

[33]  E. Wiertz,et al.  Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3 , 2007, The Journal of cell biology.

[34]  R. Guarisco,et al.  Extrahepatic manifestations of chronic HCV infection. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[35]  P. Arosio,et al.  Comparative study between Hfe‐/‐ and β2m‐/‐ mice: progression with age of iron status and liver pathology , 2006, International journal of experimental pathology.

[36]  H. Ploegh,et al.  Signal peptide peptidase is required for dislocation from the endoplasmic reticulum , 2006, Nature.

[37]  David B. Williams,et al.  Functions of ERp57 in the Folding and Assembly of Major Histocompatibility Complex Class I Molecules* , 2006, Journal of Biological Chemistry.

[38]  Stephen L. Chen,et al.  The Natural History of Hepatitis C Virus (HCV) Infection , 2006, International journal of medical sciences.

[39]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[40]  Tracey M. Filzen,et al.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail , 2004, The Journal of cell biology.

[41]  A. Mathieu,et al.  [The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis]. , 2011, Reumatismo.

[42]  P. Lapinski,et al.  Calreticulin recognizes misfolded HLA-A2 heavy chains , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  V. Engelhard Faculty Opinions recommendation of Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes. , 2002 .

[44]  B. Martoglio,et al.  Intramembrane Proteolysis of Signal Peptides: An Essential Step in the Generation of HLA-E Epitopes1 , 2001, The Journal of Immunology.

[45]  P. Stevenson,et al.  MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.

[46]  R. Pettersson,et al.  Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines. , 2001, International immunology.

[47]  K. Lindsten,et al.  Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[49]  F. Li,et al.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Mann,et al.  ER‐60, a chaperone with thiol‐dependent reductase activity involved in MHC class I assembly , 1998, The EMBO journal.

[51]  B. Martoglio,et al.  Signal peptide fragments of preprolactin and HIV‐1 p‐gp160 interact with calmodulin , 1997, The EMBO journal.

[52]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K Koike,et al.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.

[54]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[56]  P. Cresswell,et al.  Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Stefan Imreh,et al.  Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 , 1995, Nature.

[58]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[59]  M. Brandon,et al.  Lymphocyte subpopulations in the blood of sheep persistently infected with border disease virus. , 1989, Clinical and experimental immunology.